Logo_Anaqua-Color.png
Volumen der Patenterteilungen im Jahr 2023 bleibt laut Jahresbericht von Anaqua konstant
January 23, 2024 07:00 ET | Anaqua
BOSTON, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Anaqua, der führende Anbieter von Technologien für das Management von Innovation und geistigem Eigentum (IP), gab heute seine jährliche Analyse der Daten...
Logo_Anaqua-Color.png
Le rapport annuel Anaqua indique que le volume des brevets délivrés en 2023 reste stable
January 23, 2024 07:00 ET | Anaqua
BOSTON, 23 janv. 2024 (GLOBE NEWSWIRE) -- Anaqua, le fournisseur de technologie de gestion de l'innovation et de la propriété intellectuelle (PI), a publié aujourd'hui son analyse annuelle des...
Logo_Anaqua-Color.png
Annual Anaqua Data Report Finds 2023 Patent Grant Volume Holds Steady
January 23, 2024 07:00 ET | Anaqua
Anaqua's 2023 analysis and infographic of USPTO Intellectual Property patent data indicates continued innovation among US-based and global companies
BioSenic dépose une
BioSenic dépose une demande de protection supplémentaire par brevet, suite à de nouvelles preuves cliniques de l'efficacité de JTA-004 dans le traitement de l'arthrose
January 23, 2024 01:00 ET | BioSenic
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE À la suite d'une analyse post hoc d'un essai de phase 3 démontrant un soulagement de la douleur chez les patients souffrant d'arthrose sévère du...
BioSenic files for a
BioSenic files for additional patent protection following new clinical evidence of efficacy for JTA-004 in osteoarthritis
January 23, 2024 01:00 ET | BioSenic
PRESS RELEASE – INSIDE INFORMATION Following a post-hoc analysis of a Phase 3 trial demonstrating pain relief in patients with severe knee osteoarthritis, Biosenic applied for an international...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Special Meeting of Shareholders
January 18, 2024 16:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on February 20, 2024, the Company will...
digital-science-logo-bw.jpg
Digital Science announces IFI CLAIMS annual rankings: Samsung leads again in U.S. patents while Qualcomm leaps into second place; overall grants dip 3.4%
January 09, 2024 04:00 ET | Digital Science
New 2023 patent data rankings highlight escalating areas of R&D activity, according to an annual patent study by Digital Science company IFI CLAIMS.
tiziana-logo.png
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation
January 05, 2024 07:00 ET | Tiziana Life Sciences Ltd.
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist
valyant_logo huge.png
Valyant Enters into Settlement Agreement with Hi Auto and kea to Resolve Patent Litigation
December 27, 2023 08:00 ET | Valyant AI
Denver, Colo., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Valyant AI, Hi Auto, and kea have entered into a settlement agreement to resolve their pending litigation related to Valyant’s patents for voice...
sunriselogo.jpg
Sunrise New Energy Secures Highly Regarded Japanese Patent for Invention of Lithium-Ion Battery Anode Material Preparation Method
December 21, 2023 09:25 ET | Sunrise New Energy Co., Ltd
ZIBO, China, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that its patent application for the invention...